Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0700
-0.0100 (-12.50%)
Aug 28, 2026, 2:50 PM EST
Hemostemix Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.17 | 0.68 | 0.71 | 0.16 | 0.14 | 0.22 |
Short-Term Investments | 0.15 | 0.06 | - | - | - | - |
Cash & Short-Term Investments | 0.32 | 0.74 | 0.71 | 0.16 | 0.14 | 0.22 |
Cash Growth | -66.92% | 5.10% | 354.07% | 14.49% | -38.14% | -14.93% |
Other Receivables | 0.06 | 0.07 | 0.23 | 0.03 | 0.14 | 0.34 |
Receivables | 0.06 | 0.07 | 0.23 | 0.03 | 0.14 | 0.34 |
Prepaid Expenses | 0.05 | 0.04 | 0.06 | 0.13 | 0.19 | - |
Total Current Assets | 0.43 | 0.85 | 0.99 | 0.31 | 0.46 | 0.56 |
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 0.43 | 0.85 | 0.99 | 0.31 | 0.47 | 0.56 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.69 | 1.54 | 2.21 | 2.62 | 2.62 | 3.31 |
Accrued Expenses | 0.1 | 0.19 | 0.57 | 0.25 | 0 | 0.01 |
Other Current Liabilities | - | - | - | - | - | 1.04 |
Total Current Liabilities | 1.79 | 1.73 | 2.77 | 2.88 | 2.62 | 4.37 |
Long-Term Debt | 3.62 | 3.6 | 4.94 | 4.32 | 4.13 | 1.48 |
Long-Term Deferred Tax Liabilities | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 | - |
Total Liabilities | 5.9 | 5.82 | 8.2 | 7.68 | 7.23 | 5.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 48.69 | 48.38 | 43.92 | 42.48 | 41.08 | 38.67 |
Additional Paid-In Capital | 14.7 | 14.68 | 13.22 | 11.93 | 10.25 | 10.06 |
Retained Earnings | -71.39 | -70.6 | -65.88 | -63.27 | -60.76 | -55.53 |
Comprehensive Income & Other | 2.53 | 2.56 | 1.54 | 1.49 | 2.67 | 1.52 |
Shareholders' Equity | -5.47 | -4.97 | -7.2 | -7.37 | -6.77 | -5.28 |
Total Liabilities & Equity | 0.43 | 0.85 | 0.99 | 0.31 | 0.47 | 0.56 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.62 | 3.6 | 4.94 | 4.32 | 4.13 | 1.48 |
Net Cash (Debt) | -3.3 | -2.86 | -4.23 | -4.17 | -3.99 | -1.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.02 | -0.02 | -0.04 | -0.05 | -0.06 | -0.02 |
Filing Date Shares Outstanding | 197.79 | 197.82 | 145.31 | 87.12 | 75.74 | 68.2 |
Total Common Shares Outstanding | 197.79 | 195.25 | 140.64 | 87.12 | 75.74 | 59.15 |
Working Capital | -1.37 | -0.88 | -1.78 | -2.56 | -2.16 | -3.8 |
Book Value Per Share | -0.03 | -0.03 | -0.05 | -0.08 | -0.09 | -0.09 |
Tangible Book Value | -5.47 | -4.97 | -7.2 | -7.37 | -6.77 | -5.28 |
Tangible Book Value Per Share | -0.03 | -0.03 | -0.05 | -0.08 | -0.09 | -0.09 |
Machinery | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |